Alkem is the first company in India to introduce semaglutide in single-shot pre-filled syringe format, expanding treatment options for patients and lowering entry barriers with its affordable pricing.
Semaglutide is the active ingredient in certain brand-name medications prescribed for obesity, type 2 diabetes, and more. Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist ...
Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible ...
Alkem launches India’s first ready-to-use semaglutide syringe for diabetes and weight loss from ₹350
The launch comes as India grapples with rising diabetes and obesity cases, offering patients another treatment option designed to improve long-term adherence.
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what happens if you use expired semaglutide? For one, it can make the ...
Liraglutide, under the brand name, Saxenda, is FDA-approved for weight management or weight loss in some cases. Saxenda is injected daily and starts at a 0.6-milligram dose, with a maximum dose of 3 ...
The logo of Lupin is seen on the facade of its pharmaceutical plant in Verna, in the western state of Goa, India, June 9, 2017. Picture taken June 9, 2017. REUTERS/Danish Siddiqui March 17 (Reuters) - ...
A trial of 108 adults with obesity seeking treatment for alcohol use finds a once-weekly semaglutide injection reduced heavy drinking days in the past 30 days by an average of roughly 12 days, 50% ...
Morning Overview on MSN
Scientists found why Ozempic stops working for some patients
Millions of patients taking semaglutide for weight loss hit a wall after months of steady progress, watching the scale stop ...
The UK has approved a once daily Wegovy semaglutide pill for weight loss, marking Europe’s first oral GLP-1 treatment. It will initially be available via private prescription, with NHS use still under ...
As weight loss medications containing active ingredients like semaglutide continue to define a new chapter in metabolic health care, research into new, similar drugs is on the rise. Here’s everything ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results